Diploma PLC reported revenue results for the first quarter ended December 31, 2022. For the quarter, the company reported Organic revenue growth 10%: broad-based momentum in Controls, sustained strong growth at Seals and Life Sciences on track for sustainable growth as surgical procedures continue to recover. Reported revenue growth 30%: 11% contribution from high quality acquisitions and a 9% foreign exchange benefit.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,276 GBX | -1.47% | +2.25% | +19.37% |
14/05 | RBC Boosts Diploma PT, Affirms Sector Perform Rating | MT |
14/05 | Berenberg Lifts Diploma PT, Keeps Buy Recommendation | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.37% | 745.35Cr | |
+8.06% | 4.01TCr | |
+20.87% | 805.75Cr | |
-16.04% | 477.16Cr | |
+16.56% | 161.89Cr | |
+4.40% | 154.23Cr | |
+27.39% | 154.01Cr | |
+31.15% | 122.85Cr | |
-0.98% | 101.74Cr | |
+53.59% | 84Cr |
- Stock Market
- Equities
- DPLM Stock
- News Diploma PLC
- Diploma PLC Reports Revenue Results for the First Quarter Ended December 31, 2022